Effect of medication on EMG patterns in individuals with Parkinson's disease

Movement Disorders

Volumn 17, Issue 5, 2002, Pages 950-960

  Robichaud, Julie A ^a   Pfann, Kerstin D ^a   Comella, Cynthia L ^b   Corcos, Daniel M ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

EMG patterns; Medication; Movement control; Parkinson's disease

Indexed keywords

ANTIPARKINSON AGENT; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; PERGOLIDE; PRAMIPEXOLE; SELEGILINE;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DYSKINESIA; ELBOW FLEXION; ELECTROMYOGRAPHY; FEMALE; HUMAN; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0036764596     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10218     Document Type: Review

References (27)

1. Cotzias GC, Papavasiliou PS, Gellene R. Modification of parkinsonism-chronic treatment with l-dopa. N Engl J Med 1969;280: 337-345.
2. Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM. Treatment of parkinsonism with levodopa. Arch Neurol 1969;21: 343-354.
3. Karlsson S, Persson M, Johnels B. Levodopa induced on-off motor fluctuations in Parkinson's disease related to rhythmical masticatory jaw movements. J Neurol Neurosurg Psychiatry 1992;55:304-307.
4. Pedersen SW, Oberg B. Dynamic strength in Parkinson's disease. Quantitative measurements following withdrawal of medication. Eur Neurol 1993;33:97-102.
5. Brown P, Corcos DM, Rothwell JC. Does Parkinsonian action tremor contribute to muscle weakness in Parkinson's disease? Brain 1997;120:401-408.
6. Corcos DM, Chen CM, Quinn NP, McAuley J, Rothwell JC. Strength in Parkinson's disease: relationship to rate of force generation and clinical status. Ann Neurol 1996;39:79-88.
7. Baroni A, Benvenuti F, Fantini L, Pantaleo T, Urbani F. Human ballistic arm abduction movements: effects of l-dopa treatment in Parkinson's disease. Neurology 1984;34:868-876.
8. Benecke R, Rothwell JC, Dick JP, Day BL, Marsden CD. Simple and complex movements off and on treatment in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1987;50:296-303.
9. Berardelli A, Dick JP, Rothwell JC, Day BL, Marsden CD. Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1986;49:1273-1279.
10. Horak FB, Frank J, Nutt J. Effects of dopamine on postural control in Parkinsonian subjects: scaling, set, and tone. J Neurophysiol 1996;75:2380-2396.
11. Sternad D, Corcos D. Effect of task and instruction on patterns of muscle activation: Wachholder and beyond. Motor Control 2001; 5:307-336.
12. Buchman AS, Leurgans S, Gottlieb GL, Chen CH, Almeida GL, Corcos DM. Effect of age and gender in the control of elbow flexion movements. J Mot Behav 2000;32:391-399.
13. Gottlieb GL, Corcos DM, Agarwal GC. Strategies for the control of voluntary movements with one mechanical degree of freedom. Behav Brain Sci 1989;12:189-210.
14. Pfann KD, Hoffman DS, Gottlieb GL, Strick PL, Corcos DM. Common principles underlying the control of rapid, single degree-of-freedom movements at different joints. Exp Brain Res 1998; 118:35-51.
15. Berardelli A, Rothwell JC, Day BL, Kachi T, Marsden CD. Duration of the first agonist EMG burst in ballistic arm movements. Brain Res 1984;304:183-187.
16. Pfann KD, Buchman AS, Comella CL, Corcos DM. Control of movement distance in Parkinson's disease. Mov Disord 2001;16: 1048-1065.
17. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases [see comments]. J Neurol Neurosurg Psychiatry 1992;55:181-184.
18. Fahn S, Elton RL, members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease. New Jersey: MacMillan Health Care Information; 1987. p 153-163.
19. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-444.
20. Beckley DJ, Panzer VP, Remler MP, Ilog LB, Bloem BR. Clinical correlates of motor performance during paced postural tasks in Parkinson's disease. J Neurol Sci 1995;132:133-138.
21. Carboncini MC, Manzoni D, Strambi S, Bonuccelli U, Pavese N, Andre P, Rossi B. The relation between EMG activity and kinematic parameters strongly supports a role of the action tremor in Parkinsonian bradykinesia. Mov Disord 2001;16:47-57.
22. Vaillancourt DE, Newell KM. The dynamics of resting and postural tremor in Parkinson's disease. Clin Neurophysiol 2000;111: 2046-2056.
23. Hallett M, Khoshbin S. A physiological mechanism of bradykinesia. Brain 1980;103:301-314.
24. Brown P, Corcos DM, Rothwell JC. Action tremor and weakness in Parkinson's disease: a study of the elbow extensors. Mov Disord 1998;13:56-60.
25. Pfann KD, Penn RD, Shannon KM, Corcos DM. Pallidotomy and bradykinesia: implications for basal ganglia function. Neurology 1998;51:796-803.
26. Pfann KD, Penn RD, Shannon KM, Shapiro MB, Corcos DM. Effect of stimulation in the ventral intermediate nucleus of the thalamus on limb control in Parkinson's disease: a case study. Mov Disord 1996;11:311-316.
27. Haslinger B, Erhard P, Kampfe N, Boecker H, Rummeny E, Schwaiger M, Conrad B, Ceballos-Baumann AO. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 2001;124:558-570.